GEn1E Lifesciences
YC S19San Francisco, US · Founded 2018 · Delaware corporation · 5 known investors
Gen1e builds healthcare solutions supported by a network of physicians across hospitals and medical centers.
Also known as Inc.
AI & Machine LearningBiotechHealthtechMedical DevicesArtificial IntelligenceHealthcareDrug discoveryUnited States of AmericaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (S19)
GEn1E Lifesciences was founded in 2018 by Ritu Lal.
RL
Ritu LalinFounder
SB
Soujanya BhumkarExecutive
Board
NK
Noor KamruddinBoard director
FN
Francois NaderBoard director
AL
Alan LevyBoard director
Investors · 5
.png)
Reported raises · per SEC filings
Form D private placements$22.5M disclosed across 2 rounds · 2022–2025
▶$5.5MraisedDec 2025 · 44 investors · BiotechnologyRule 506(b)
▶$5.5MraisedDec 2025 · 44 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ritu LalExecutive Officer, Director
- Francois NaderDirector
- Alan LevyDirector
- Noor KamruddinDirector
- Soujanya BhumkarExecutive Officer, Director
- Offering amount
- $11.9M
- Amount sold
- $5.5M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17MraisedDec 2022 · 89 investors · OtherRule 506(b)
▶$17MraisedDec 2022 · 89 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Dr. Alan LevyDirector
- Soujanya BhumkarDirector
- Noor KamruddinDirector
- Ritu LalExecutive Officer, Director
- Offering amount
- $18.2M
- Amount sold
- $17M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapGenomeweb10 shared keywordsGenomeWeb's Research Funding section publishes news coverage of research grants and government funding trends in genetics, genomics, and molecular diagnostics. It is an industry news publication serving researchers and organizations in the life sciences.
Generate Biomedicines9 shared keywordsGenerate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering. The company creates new drugs on demand across diverse biologic modalities for immunology, oncology, infectious disease, and vaccines.
Regeneron NASDAQ: REGN www.regeneron.com9 shared keywordsRegeneron is a biopharmaceutical company that develops medicines ranging from biologics to genetic medicines for people with serious diseases across areas such as metabolic disease, ophthalmology, and rare diseases. It runs research and development programs and clinical trials aimed at treating conditions including generalized myasthenia gravis.
Genialis8 shared keywordsGenialis is a precision oncology company that applies data analysis to help drug developers understand mechanisms of action, resistance, and patient stratification for cancer therapies. It supports pharmaceutical partners in advancing molecules through clinical trials toward becoming effective medicines.
Elegen7 shared keywordsElegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.
Companies competing with GEn1E Lifesciences for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Nykaa Stock And 2 Fast Growth Picks With High Insider Ownership - Simply Wall St Newssimplywall.st · Jul 2026Frequently asked questions
- What does GEn1E Lifesciences do?
- Gen1e builds healthcare solutions supported by a network of physicians across hospitals and medical centers.
- Who founded GEn1E Lifesciences?
- GEn1E Lifesciences was founded by Ritu Lal in 2018.
- Who are GEn1E Lifesciences's investors?
- GEn1E Lifesciences's investors include Clear Ventures, Y Combinator, Khosla Ventures, Harmonix Fund, Inflect Health.
- How much funding has GEn1E Lifesciences raised?
- GEn1E Lifesciences has disclosed $22.5M raised across 2 rounds.
- Where is GEn1E Lifesciences headquartered?
- GEn1E Lifesciences is headquartered in San Francisco, US.